Русский
Effect Of Alpha-lipoic Acid (tiogamma) On The Quality Of Life Of Patients With Diabetic Peripheral Polyneuropathy
L.A. Kapustina, O.S. Nesterova, A.N. Boiko, I.D. Stulin, M.B. Anciferov
Effect of alpha-lipoic acid (Tiogamma) on the quality of life of patients with diabetic peripheral polyneuropathy
The results of the study, including 200 patients with type 1 and type 2 diabetes mellitus (type 1 diabetes and type 2 diabetes) complicated by diabetic peripheral neuropathy (DPN), which assessed changes in quality of life of patients before and after treatment with medication alpha-lipoic acid – Tiagamma- are presented. Use of Tiagamma in the treatment of DPN in patients with type 1 diabetes and type 2 diabetes in outpatient practice leads to a significant decrease in DPN symptoms, improvement of characteristics of carbohydrate and lipid metabolism, reduction of depression manifestations, and improvement of quality of life.
The results of the study, including 200 patients with type 1 and type 2 diabetes mellitus (type 1 diabetes and type 2 diabetes) complicated by diabetic peripheral neuropathy (DPN), which assessed changes in quality of life of patients before and after treatment with medication alpha-lipoic acid – Tiagamma- are presented. Use of Tiagamma in the treatment of DPN in patients with type 1 diabetes and type 2 diabetes in outpatient practice leads to a significant decrease in DPN symptoms, improvement of characteristics of carbohydrate and lipid metabolism, reduction of depression manifestations, and improvement of quality of life.
